<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82705">
  <stage>Registered</stage>
  <submitdate>28/03/2008</submitdate>
  <approvaldate>2/05/2008</approvaldate>
  <actrnumber>ACTRN12608000227392</actrnumber>
  <trial_identification>
    <studytitle>Bacille Calmette-Guérin (BCG) Immune Response Study</studytitle>
    <scientifictitle>Improving protection against childhood tuberculosis: the influence of Bacille Calmette-Guérin (BCG) vaccine strain and age on protective immunity</scientifictitle>
    <utrn />
    <trialacronym>BIRS</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Tuberculosis</healthcondition>
    <healthcondition>Immune response after BCG vaccine</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Use of three different BCG vaccine strains (BCG-Denmark, BCG-Japan, BCG-Russia) for immunisation at birth. Immunisation at 2 months of age with one BCG vaccine strain (BCG-Denmark). In all study groups 0.05ml of BCG will be administered intradermally.</interventions>
    <comparator>BCG vaccine strains will be compared with one another. Dose under 1 year of age 0.05 ml. Infants immunised at birth will be compared with those immunised at 2 months of age.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Frequency of cytokine (eg interferon-gamma) producing T cells measured by flow cytometry in samples after in vitro stimulation.</outcome>
      <timepoint>10 weeks after immunisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Qualitative immune response measured as the pattern of cytokine producing T cells measured with flow cytometry and in supernatants using a multiplex bead array system.</outcome>
      <timepoint>10 weeks after immunisation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Term, well newborn infants.</inclusivecriteria>
    <inclusiveminage>1</inclusiveminage>
    <inclusiveminagetype>Days</inclusiveminagetype>
    <inclusivemaxage>2</inclusivemaxage>
    <inclusivemaxagetype>Months</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Family history of immunodeficiencies. Mother with HIV. Mother with active TB.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Consenting mothers/families in antenatal clinic. Randomisation of newborn infants to one of four groups at birth using seald opaque envelopes.</concealment>
    <sequence>Stratified allocation using three broad ethnical groups: Parents originating form Africa, Indian Subcontinent, Asia.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>26/04/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>256</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>The Mercy Hospital for Women</primarysponsorname>
    <primarysponsoraddress>163 Studley Road, Heidelberg 3084, VIC</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Murdoch Children's Research Institute</fundingname>
      <fundingaddress>Flemington Rd
Parkville, VIC 3052</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Nossal Institute of Global Health</fundingname>
      <fundingaddress>Faculty of Medicine, Dentistry and Health Sciences
The University of Melbourne
Victoria 3010 Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Swiss National Science Foundation</fundingname>
      <fundingaddress>Wildhainweg 3, POBox 8232, 3001 Berne</fundingaddress>
      <fundingcountry>Switzerland</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>The University of Melbourne</fundingname>
      <fundingaddress>Faculty of Medicine, Dentistry and Health Sciences
The University of Melbourne
Victoria 3010 Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>European Society for Paediatric Infectious Diseases</fundingname>
      <fundingaddress>c/o Kenes International
Rue de Chantepoulet 1-3
P.O.Box 1726
CH-1211 Geneva 1

  
Telephone: +41 22 906 91 65 
  
Fax:  +41 22 732 2607</fundingaddress>
      <fundingcountry>Switzerland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is investigating the influence of vaccine strain and age at immunisation on the immune response in children to Bacille Calmette-Guérin (BCG) immunisation. The underlying hypothesis is that there is a measurable difference in the qualtitative and qualitative immune response which may be associated with differences in the level of protection</summary>
    <trialwebsite />
    <publication>Ritz N, Hanekom, W, Robins-Browne R, Britton W, Curtis N. The influence of BCG vaccine strain on the immune response and protection against tuberculosis. 
FEMS Microbiology Reviews 2008 in press.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee, Mercy Hospital for Women</ethicname>
      <ethicaddress>163 Studley Road, Heidelberg 3084, VIC</ethicaddress>
      <ethicapprovaldate>7/12/2007</ethicapprovaldate>
      <hrec>R07/16</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Nicole Ritz</name>
      <address>Royal Children's Hospital Melbourne
Flemington Road
Parkville 3052, VIC</address>
      <phone>03 9345 4990</phone>
      <fax />
      <email>nicole.ritz@rch.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Nigel Curtis</name>
      <address>Royal Children's Hospital Melbourne
Flemington Road
Parkville 3052, VIC</address>
      <phone>03 9345 6366</phone>
      <fax />
      <email>nigel.curtis@rch.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Nicole Ritz</name>
      <address>Royal Children's Hospital Melbourne</address>
      <phone>03 9345 6664</phone>
      <fax />
      <email>nicole.ritz@rch.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>